While Cures Within Reach is disease-agnostic, we are dedicated to improving the quality and length of life for patients living with a neurological disease (either mental health or neurodegenerative) through the speed and cost-effectiveness of medical repurposing.

Our events and research within the Neurology Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.

Open Funding Opportunity RFPs for Neurology:

Clinical Repurposing Research to Impact Veteransup to $50,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans, including mental health, PTSD and brain injuries. Proposal submissions due February 26, 2021. More information on our RFP page.



Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.

How Patients Impact the 505(b)(2) Regulatory Process
October 2020
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.

CureAccelerator Live for Chicago 2020
September 2020
Four finalists from the greater Chicago area competing for up to $50,000 to fund their repurposing clinical trials.

Repurposing Drugs for Alzheimer’s Disease
November 2019
New York, NY
In conjunction with the Alzheimer’s Drug Discovery Foundation, a patient education panel of renowned scientists discussing the role of repurposing in treating Alzheimer’s disease, during ADDF’s annual Hope on the Horizon event.

CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.